Due Date Reminder for FDA Discussion Paper on Considerations for the Regulation of Generative AI-Enabled Medical Devices
The FDA requests feedback by October 19, 2026, on considerations for the regulation of generative AI-enabled medical devices.

This email was sent to Minuty@podam.pl using Granicus Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
Granicus Communications logo